Menu
Back to User profile » Dr Colin Reisner
Papers published by Dr Colin Reisner:
Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Lung Function versus Monotherapies in GOLD Category A Patients with COPD: Pooled Data from the Phase III PINNACLE Studies
Martinez FJ, Rabe KF, Lipworth BJ, Arora S, Jenkins M, Martin UJ, Reisner C
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:99-106
Published Date: 9 January 2020
Efficacy And Safety Of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (GFF MDI) Formulated Using Co-Suspension Delivery Technology In Chinese Patients With COPD
Chen R, Zhong N, Wang HY, Zhao L, Mei X, Qin Z, Huang J, Assam PN, Maes A, Siddiqui S, Martin UJ, Reisner C
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:43-56
Published Date: 8 January 2020
Long-Term Safety and Efficacy of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD
Ichinose M, Fukushima Y, Inoue Y, Hataji O, Ferguson GT, Rabe KF, Hayashi N, Okada H, Takikawa M, Bourne E, Ballal S, DeAngelis K, Aurivillius M, Reisner C, Dorinsky P
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:2993-3002
Published Date: 23 December 2019
Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD: A Subgroup Analysis of the KRONOS Study
Ichinose M, Fukushima Y, Inoue Y, Hataji O, Ferguson GT, Rabe KF, Hayashi N, Okada H, Takikawa M, Bourne E, Ballal S, DeAngelis K, Aurivillius M, Dorinsky P, Reisner C
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:2979-2991
Published Date: 23 December 2019
Improved lung function and patient-reported outcomes with co-suspension delivery technology glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a randomized Phase III study conducted in Asia, Europe, and the USA
Lipworth BJ, Collier DJ, Gon Y, Zhong NS, Nishi K, Chen R, Arora S, Maes A, Siddiqui S, Reisner C, Martin UJ
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:2969-2984
Published Date: 26 September 2018
A randomized study using functional respiratory imaging to characterize bronchodilator effects of glycopyrrolate/formoterol fumarate delivered by a metered dose inhaler using co-suspension delivery technology in patients with COPD
De Backer W, De Backer J, Vos W, Verlinden I, Van Holsbeke C, Clukers J, Hajian B, Siddiqui S, Jenkins M, Reisner C, Martin UJ
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:2673-2684
Published Date: 30 August 2018
Efficacy and safety of four doses of glycopyrrolate/formoterol fumarate delivered via a metered dose inhaler compared with the monocomponents in patients with moderate-to-severe COPD
Reisner C, Pearle J, Kerwin EM, St Rose E, Darken P
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:1965-1977
Published Date: 19 June 2018
Efficacy, safety, and pharmacokinetics of budesonide/formoterol fumarate delivered via metered dose inhaler using innovative co-suspension delivery technology in patients with moderate-to-severe COPD
Kerwin EM, Siler TM, Arora S, Darken P, St Rose E, Reisner C
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:1483-1494
Published Date: 8 May 2018